References
- Van Binsbergen JJ, Grundmeyer HGLM, Van den Hoogen JPH, Van Kruysdijk M, Prins A, van Ree JW, et al. NHG-standaard hypertensie. Huisarts en Wetenschap 1991; 34: 389–95
- Walma EP, Grundmeyer HGLM, Thomas S, Prins A, Van den Hoogen JPH, Van der Laan JR. NHG-standaard hypertensie (eerste herziening). Huisarts en Wetenschap 1997; 40(12)598–617
- Walma EP, Thomas S, Prins A, Grundmeyer HGLM, Van der Laan JR, Wiersma T. NHG-standaard hypertensie (derde herziening). Huisarts en Wetenschap 2003; 46(8)435–49
- Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28(12)1462–536
- Summary of 1993 World Health Organisation. International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison Committee. BMJ 1993;307(6918):1541–6.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19)2560–72
- Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation 2005; 112(11)1651–62
- Manning G, Brooks A, Slinn B, Millar-Craig MW, Donnelly R. Assessing blood pressure control in patients treated for hypertension: comparing different measurements and targets. Br J Gen Pract 2006; 56(526)375–7
- Nederlands Huisartsen Genootschap. NHG-Standaard Cardiovasculair Risicomanagement. Publisher: Bohn Stafleu van Loghum. Utrecht. 2006. ISBN 9031347213.
- Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003; 290(2)199–206
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455)217–23
- Walley T, Duggan AK, Haycox AR, Niziol CJ. Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 2003; 96(11)525–31
- Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, et al. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol 2004; 60(2)135–42
- Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350(9080)757–64
- Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288(23):2981–97.
- Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265(24):3255–64.